These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35960210)

  • 1. Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine.
    Wang H; Chan KYY; Cheng CK; Ng MHL; Lee PY; Cheng FWT; Lam GKS; Chow TW; Ha SY; Chiang AKS; Leung WH; Leung AYH; Wang CC; Zhang T; Zhang XB; So CC; Yuen YP; Sun Q; Zhang C; Xu Y; Cheung JTK; Ng WH; Tang PM; Kang W; To KF; Lee WYW; Wong RSM; Poon ENY; Zhao Q; Huang J; Chen C; Yuen PMP; Li CK; Leung AWK; Leung KT
    Blood Cancer Discov; 2022 Nov; 3(6):516-535. PubMed ID: 35960210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.
    Malani D; Kumar A; Brück O; Kontro M; Yadav B; Hellesøy M; Kuusanmäki H; Dufva O; Kankainen M; Eldfors S; Potdar S; Saarela J; Turunen L; Parsons A; Västrik I; Kivinen K; Saarela J; Räty R; Lehto M; Wolf M; Gjertsen BT; Mustjoki S; Aittokallio T; Wennerberg K; Heckman CA; Kallioniemi O; Porkka K
    Cancer Discov; 2022 Feb; 12(2):388-401. PubMed ID: 34789538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
    Pemovska T; Kontro M; Yadav B; Edgren H; Eldfors S; Szwajda A; Almusa H; Bespalov MM; Ellonen P; Elonen E; Gjertsen BT; Karjalainen R; Kulesskiy E; Lagström S; Lehto A; Lepistö M; Lundán T; Majumder MM; Marti JM; Mattila P; Murumägi A; Mustjoki S; Palva A; Parsons A; Pirttinen T; Rämet ME; Suvela M; Turunen L; Västrik I; Wolf M; Knowles J; Aittokallio T; Heckman CA; Porkka K; Kallioniemi O; Wennerberg K
    Cancer Discov; 2013 Dec; 3(12):1416-29. PubMed ID: 24056683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
    Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Montesinos P
    Expert Rev Hematol; 2020 Oct; 13(10):1057-1065. PubMed ID: 32869672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study.
    Swords RT; Azzam D; Al-Ali H; Lohse I; Volmar CH; Watts JM; Perez A; Rodriguez A; Vargas F; Elias R; Vega F; Zelent A; Brothers SP; Abbasi T; Trent J; Rangwala S; Deutsch Y; Conneally E; Drusbosky L; Cogle CR; Wahlestedt C
    Leuk Res; 2018 Jan; 64():34-41. PubMed ID: 29175379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of Recurrent Protein Expression Patterns in Pediatric Acute Myeloid Leukemia Identified New Therapeutic Targets.
    Hoff FW; Hu CW; Qiu Y; Ligeralde A; Yoo SY; Mahmud H; de Bont ESJM; Qutub AA; Horton TM; Kornblau SM
    Mol Cancer Res; 2018 Aug; 16(8):1275-1286. PubMed ID: 29669821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets.
    Stratmann S; Yones SA; Mayrhofer M; Norgren N; Skaftason A; Sun J; Smolinska K; Komorowski J; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Cavelier L; Holmfeldt L
    Blood Adv; 2021 Feb; 5(3):900-912. PubMed ID: 33560403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial.
    Burd A; Levine RL; Ruppert AS; Mims AS; Borate U; Stein EM; Patel P; Baer MR; Stock W; Deininger M; Blum W; Schiller G; Olin R; Litzow M; Foran J; Lin TL; Ball B; Boyiadzis M; Traer E; Odenike O; Arellano M; Walker A; Duong VH; Kovacsovics T; Collins R; Shoben AB; Heerema NA; Foster MC; Vergilio JA; Brennan T; Vietz C; Severson E; Miller M; Rosenberg L; Marcus S; Yocum A; Chen T; Stefanos M; Druker B; Byrd JC
    Nat Med; 2020 Dec; 26(12):1852-1858. PubMed ID: 33106665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A precision medicine classification for treatment of acute myeloid leukemia in older patients.
    Mims AS; Kohlschmidt J; Borate U; Blachly JS; Orwick S; Eisfeld AK; Papaioannou D; Nicolet D; Mrόzek K; Stein E; Bhatnagar B; Stone RM; Kolitz JE; Wang ES; Powell BL; Burd A; Levine RL; Druker BJ; Bloomfield CD; Byrd JC
    J Hematol Oncol; 2021 Jun; 14(1):96. PubMed ID: 34162404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute myeloid leukemia in the next decade - Towards real-time functional testing and personalized medicine.
    Lam SS; He AB; Leung AY
    Blood Rev; 2017 Nov; 31(6):418-425. PubMed ID: 28797519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Precision medicine for acute myeloid leukemia based on genomic profiling].
    Sanada M
    Rinsho Ketsueki; 2019; 60(7):847-853. PubMed ID: 31391376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
    Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
    Blood Adv; 2019 Oct; 3(20):3157-3169. PubMed ID: 31648321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine for acute myeloid leukemia.
    Lai C; Karp JE; Hourigan CS
    Expert Rev Hematol; 2016 Jan; 9(1):1-3. PubMed ID: 26514194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
    Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
    Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An
    Lin S; Larrue C; Scheidegger NK; Seong BKA; Dharia NV; Kuljanin M; Wechsler CS; Kugener G; Robichaud AL; Conway AS; Mashaka T; Mouche S; Adane B; Ryan JA; Mancias JD; Younger ST; Piccioni F; Lee LH; Wunderlich M; Letai A; Tamburini J; Stegmaier K
    Cancer Discov; 2022 Feb; 12(2):432-449. PubMed ID: 34531254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia.
    Lilljebjörn H; Orsmark-Pietras C; Mitelman F; Hagström-Andersson A; Fioretos T
    Semin Cancer Biol; 2022 Sep; 84():40-49. PubMed ID: 34606984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.
    Collignon A; Hospital MA; Montersino C; Courtier F; Charbonnier A; Saillard C; D'Incan E; Mohty B; Guille A; Adelaïde J; Carbuccia N; Garnier S; Mozziconacci MJ; Zemmour C; Pakradouni J; Restouin A; Castellano R; Chaffanet M; Birnbaum D; Collette Y; Vey N
    Blood Cancer J; 2020 Jun; 10(6):64. PubMed ID: 32488055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Villenet C; Petit A; Rousseau A; Ng SWK; Paquet A; Gonzales F; Barthélémy A; Leprêtre F; Pottier N; Nelken B; Michel G; Baruchel A; Bertrand Y; Leverger G; Lapillonne H; Figeac M; Dick JE; Wang JCY; Preudhomme C; Cheok M
    Leukemia; 2019 Feb; 33(2):348-357. PubMed ID: 30089916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression.
    Stratmann S; Yones SA; Garbulowski M; Sun J; Skaftason A; Mayrhofer M; Norgren N; Herlin MK; Sundström C; Eriksson A; Höglund M; Palle J; Abrahamsson J; Jahnukainen K; Munthe-Kaas MC; Zeller B; Tamm KP; Cavelier L; Komorowski J; Holmfeldt L
    Blood Adv; 2022 Jan; 6(1):152-164. PubMed ID: 34619772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.
    Simonetti G; Padella A; do Valle IF; Fontana MC; Fonzi E; Bruno S; Baldazzi C; Guadagnuolo V; Manfrini M; Ferrari A; Paolini S; Papayannidis C; Marconi G; Franchini E; Zuffa E; Laginestra MA; Zanotti F; Astolfi A; Iacobucci I; Bernardi S; Sazzini M; Ficarra E; Hernandez JM; Vandenberghe P; Cools J; Bullinger L; Ottaviani E; Testoni N; Cavo M; Haferlach T; Castellani G; Remondini D; Martinelli G
    Cancer; 2019 Mar; 125(5):712-725. PubMed ID: 30480765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.